Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000215478

Medchemexpress LLC N-[[3-[[3-[(5-chlorothiophen-2-yl)sulfonylamino]-4-methoxyindazol-1-yl]methyl]phenyl]methyl]-2-hydrox | 1240516-71-5 | MFCD30533311 | 99.8% | 549.06 g/mol | C24H25ClN4O5S2 | 100 MG
SDP

Catalog No. 5000215478
Encompass_Preferred

GSK2239633A is a small-molecule CCR4 antagonist used in research to inhibit [125I]-TARC binding to human CCR4 (reported pIC50 7.96). It is supplied as a high-purity solid with defined storage recommendations and high solubility in DMSO for assay preparation.

  • High purity suitable for research assays.
  • Selective CCR4 antagonistic activity (pIC50 7.96).
  • Solid form with recommended freezer storage.
  • High solubility in DMSO for stock preparation.
  • Molecular weight 549.06 g/mol and formula C24H25ClN4O5S2.
  • For research use only; not for human or diagnostic use.

Catalog No. 50-002-15478 Supplier Medchemexpress LLC Supplier No. HY100183100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GSK2239633A is a small-molecule CCR4 antagonist used in research to inhibit [125I]-TARC binding to human CCR4 (reported pIC50 7.96). It is supplied as a high-purity solid with defined storage recommendations and high solubility in DMSO for assay preparation.

  • High purity suitable for research assays.
  • Selective CCR4 antagonistic activity (pIC50 7.96).
  • Solid form with recommended freezer storage.
  • High solubility in DMSO for stock preparation.
  • Molecular weight 549.06 g/mol and formula C24H25ClN4O5S2.
  • For research use only; not for human or diagnostic use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.